Mandel H G
Science. 1983 Jul 22;221(4608):338-40. doi: 10.1126/science.6867712.
Because of the prospect of a serious decline in the nation's biomedical research capacity owing to diminished federal appropriations, temporary measures should be initiated promptly by the National Institutes of Health to preserve the stability of resources and diversity of research required for future productivity. It is recommended that the available funds be distributed in such a way as to permit some support for 50 percent of competing grant applications approved by the National Institutes of Health study sections. Measures proposed for consideration are a sliding scale for funding, a greater across-the-board reduction, a limit on support for an individual laboratory, and a review of indirect costs.
由于联邦拨款减少,国家生物医学研究能力有望严重下降,美国国立卫生研究院应立即采取临时措施,以维持未来生产力所需的资源稳定性和研究多样性。建议以这样一种方式分配可用资金,即对国立卫生研究院各研究小组批准的50%的竞争性拨款申请提供一定支持。提议供审议的措施包括资金的滑动比例、更大幅度的全面削减、对单个实验室支持的限制以及对间接成本的审查。